SLV313 (1-(2,3-Dihydro-Benzo[1,4]Dioxin-5-yl)-4- [5-(4-Fluoro-Phenyl)-Pyridin-3-ylmethyl]-Piperazine Monohydrochloride): A Novel Dopamine D2 Receptor Antagonist and 5-HT1A Receptor Agonist Potential Antipsychotic Drug

Andrew C. McCreary, Jeffrey Glennon, Charles R. Ashby, Herbert Y. Meltzer, Zhu Li, J.H. Reinders, M.B. Hesselink, Stephen Long, Arnoud H. J. Herremans, Herman H. van Stuivenberg,

Neuropsychopharmacology · 2006 · 58 citations · 76 references

Concepts

References

76